Aller au contenu principal
2026 conference-abstract

Abstract 1413: Targetable gene dependencies in Ewing sarcoma subtypes.

0Citations signalées — pas une note de qualité
5Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

Abstract Ewing sarcoma (EwS) is a bone and soft tissue cancer primarily driven by a FET::ETS fusion protein, most commonly EWS::FLI1. While localized tumors have a five-year survival rate of 70-80% with multimodal treatment, the prognosis for relapsed or metastatic disease remains dismal, with survival rates below 30%. This underscores the urgent need for improved prognostic markers and innovative therapeutic strategies. Using an unsupervised hierarchical clustering approach - RACCOON - we identified three distinct transcriptional subtypes of EwS: EWS::FLI1-high, mesenchymal-like, and muscle-like. The muscle-like group, potentially arising from myofiber infiltration, formed a separate cluster, while the remainder of the cohort was distributed along a continuum of transcriptional states between the EWS::FLI1-high and EWS::FLI1-low/mesenchymal extremes. The same variability in these two transcriptional programs was observed at single-cell resolution and across commonly used preclinical EwS models. Subtype classification in clinical cohorts revealed significant survival differences, with mesenchymal-like tumors showing the poorest prognosis (<35% five-year overall survival) and the highest metastatic potential. An in vivo experiment in patient-derived xenografts (PDXs) reinforced these findings, as mesenchymal-like tumors exhibited significantly greater metastatic potential. Additionally, functional genomics data from CRISPR-screened cell lines identified subtype-specific gene dependencies - the Fanconi anemia pathway emerged as a promising therapeutic target for EWS::FLI1-high tumors, while mesenchymal-like tumors showed reliance on distinct transcriptional regulators. By integrating transcriptomic profiling with functional genomics, this study highlights the biological and clinical heterogeneity of EwS, offering novel insights into its molecular underpinnings and paving the way for personalized treatment strategies tailored to specific transcriptional subtypes. Citation Format: Dusan Pesic, Josh Nash, Timmy Wen, Pedro Lemos Ballester, Livia Garzia, Olivier Delattre, David Malkin, Adam Shlien. Targetable gene dependencies in Ewing sarcoma subtypes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1413.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Abstract 1413: Targetable gene dependencies in Ewing sarcoma subtypes.
Date Crossref
03/04/2026
Éditeur
American Association for Cancer Research (AACR)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Sarcoma Diagnosis and TreatmentCancer Genomics and DiagnosticsProtein Degradation and Inhibitors

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.